Drug Pricing Legislation In The US May Be Losing Momentum

House subcommittee hearing on drug price negotiation bill championed by Speaker Nancy Pelosi showcases strong Republican opposition, and Senate Finance Committee Chairman Chuck Grassley suggests his bill may not be ready for a floor vote until next year.

American Election lightsprint
Politics Over Progress On Drug Pricing?

Prospects for passing US legislation to control drug prices this year are dimming after House Democrats have likely undercut their opportunities for an alliance with President Trump by opening an impeachment investigation against him. Any deal-making on a pricing bill seemed essential to overcoming resistance from congressional Republicans, especially in the Senate.

In the House, the key component of legislation developed under the leadership of Speaker Nancy Pelosi, D-CA, met with strong...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access